Epidemiology of Prostate and Testicular Cancer

Overview

Journal Semin Intervent Radiol

Specialty Radiology

Date 2016 Sep 2

PMID 27582605

Citations 16

Authors

Pauline Filippou

James E Ferguson 3rd

Matthew E Nielsen

Affiliations

Soon will be listed here.

Abstract

Prostate and testicular cancers account for a large percentage of cancer morbidity in men in the United States and worldwide due to high prevalence rates that continue to grow. Patterns of incidence and mortality vary greatly in both cancers among men of different age groups, ethnicities, and geographic locations. This article summarizes the incidence, prognosis, and risk factors of both prostate and testicular cancers, globally and in the United States.

Citing Articles

A Survey on the Knowledge and Awareness of Testicular Cancer and Testicular Self-Examination Among Men in Saudi Arabia.

Altowaijri K, Aldehaim M, Alshammari O, Aldohan R, AlTabbaa F, Kazi A Cureus. 2024; 16(3):e55778.

PMID: 38586720 PMC: 10999108. DOI: 10.7759/cureus.55778.

Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane.

Rizaner N, Fraser S, Gul I, Purut E, Djamgoz M, Altun S J Membr Biol. 2024; 257(1-2):17-24.

PMID: 38165418 DOI: 10.1007/s00232-023-00302-z.

The role of RNA modification in urological cancers: mechanisms and clinical potential.

Zhou X, Zhu H, Luo C, Yan Z, Zheng G, Zou X Discov Oncol. 2023; 14(1):235.

PMID: 38117350 PMC: 10733275. DOI: 10.1007/s12672-023-00843-8.

Humor-Based Messaging in Testicular Cancer Awareness Campaigns: A Comparative Critical Review.

Rovito M, Allen K, Perez A, Albaladejo F, Craycraft M Am J Mens Health. 2023; 17(6):15579883231215343.

PMID: 38044499 PMC: 10697052. DOI: 10.1177/15579883231215343.

Genetic determinants for the racial disparities in the risk of prostate and testicular cancers.

Uzamere I, Wang Y, Zheng T, Zhu Y Commun Med (Lond). 2022; 2(1):138.

PMID: 36352009 PMC: 9630379. DOI: 10.1038/s43856-022-00205-5.

References

Verhage B, Aben K, Witjes J, Straatman H, Schalken J, Kiemeney L . Site-specific familial aggregation of prostate cancer. Int J Cancer. 2004; 109(4):611-7. DOI: 10.1002/ijc.20015. View

Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y . Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer. 2008; 123(2):430-435. DOI: 10.1002/ijc.23500. View

Le Cornet C, Lortet-Tieulent J, Forman D, Beranger R, Flechon A, Fervers B . Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer. 2013; 50(4):831-9. DOI: 10.1016/j.ejca.2013.11.035. View

Howard G, Anderson R, Russell G, Howard V, Burke G . Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol. 2000; 10(4):214-23. DOI: 10.1016/s1047-2797(00)00038-7. View

Carter B, Beaty T, Steinberg G, Childs B, Walsh P . Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992; 89(8):3367-71. PMC: 48868. DOI: 10.1073/pnas.89.8.3367. View

Grossfeld G, Latini D, Downs T, Lubeck D, Mehta S, Carroll P . Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol. 2002; 168(6):2510-5. DOI: 10.1016/S0022-5347(05)64179-1. View

Stevenson S, Lowrance W . Epidemiology and Diagnosis of Testis Cancer. Urol Clin North Am. 2015; 42(3):269-75. DOI: 10.1016/j.ucl.2015.04.001. View

Roetzheim R, Pal N, Tennant C, Voti L, Ayanian J, Schwabe A . Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999; 91(16):1409-15. DOI: 10.1093/jnci/91.16.1409. View

Beilin J, Ball E, Favaloro J, Zajac J . Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol. 2000; 25(1):85-96. DOI: 10.1677/jme.0.0250085. View

10.

Zhou C, Check D, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J . Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer. 2015; 138(6):1388-400. PMC: 4712103. DOI: 10.1002/ijc.29894. View

11.

Gaston K, Kim D, Singh S, Ford 3rd O, Mohler J . Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol. 2003; 170(3):990-3. DOI: 10.1097/01.ju.0000079761.56154.e5. View

12.

McGlynn K, Trabert B . Adolescent and adult risk factors for testicular cancer. Nat Rev Urol. 2012; 9(6):339-49. PMC: 4031676. DOI: 10.1038/nrurol.2012.61. View

13.

Hoffman R, Meisner A, Arap W, Barry M, Shah S, Zeliadt S . Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012. Cancer Epidemiol Biomarkers Prev. 2015; 25(2):259-63. DOI: 10.1158/1055-9965.EPI-15-0723. View

14.

Fossa S, Chen J, Schonfeld S, McGlynn K, McMaster M, Gail M . Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst. 2005; 97(14):1056-66. DOI: 10.1093/jnci/dji185. View

15.

Schaid D, McDonnell S, Blute M, Thibodeau S . Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet. 1998; 62(6):1425-38. PMC: 1377141. DOI: 10.1086/301862. View

16.

Rosen A, Jayram G, Drazer M, Eggener S . Global trends in testicular cancer incidence and mortality. Eur Urol. 2011; 60(2):374-9. DOI: 10.1016/j.eururo.2011.05.004. View